Filter
374
Filtered Results: 374
Text search:
Revised
National
TB
Control
Programme,
Ministry
of
Health
India
Featured
Recommendations
34
New Publications
147
Language
Document type
No document type
261
Guidelines
39
Studies & Reports
38
Manuals
14
Strategic & Response Plan
13
Training Material
5
Situation Updates
4
Countries / Regions
India
94
Nepal
22
Myanmar / Burma
15
Global
12
Bangladesh
10
Nigeria
9
Uganda
8
Kenya
7
Malawi
7
South–East Asia Region
7
Sierra Leone
4
Asia
4
Tanzania
4
South Africa
4
Ethiopia
4
Indonesia
4
Senegal
3
Mozambique
3
Cambodia
3
Liberia
3
Pakistan
3
Thailand
2
Rwanda
2
Zimbabwe
2
Africa
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
2
Western and Central Europe
2
East and Southern Africa
2
Namibia
2
Botswana
2
Zambia
2
Colombia
1
Timor Leste/ East Timor
1
Lesotho
1
Ghana
1
Laos
1
Afghanistan
1
Philippines
1
Guinea
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
North America
1
Maldives
1
Argentina
1
Vietnam
1
Eastern Europe
1
Sri Lanka
1
Sudan
1
Georgia
1
Central African Republic
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
191
Clinical Guidelines
32
Public Health
13
Women & Child Health
9
Pharmacy & Technologies
7
Key Resources
6
Capacity Building
1
Toolboxes
TB
66
HIV
46
AMR
14
COVID-19
10
Caregiver
9
NTDs
9
Rapid Response
6
Polio
6
Global Health Education
6
Mental Health
5
Refugee
5
Disability
4
Health Financing Toolbox
4
Planetary Health
3
Pharmacy
3
Natural Hazards
2
Ebola & Marburg
2
Conflict
2
Specific Hazards
1
Cholera
1
NCDs
1
Malaria
1
Practical Guideline for collaborative interventions
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
2nd edition. Essential guideline for humanitarian assistance
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
Practical Guidance for collaborative interventions
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
The social protection landscape for people affected by TB in the WHO South-East Asia Region
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a...
WHO recommends that a...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Technical Report
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
